IACOTUCCI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 635
EU - Europa 360
AS - Asia 239
AF - Africa 10
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.248
Nazione #
US - Stati Uniti d'America 629
IT - Italia 227
SG - Singapore 119
CN - Cina 69
NL - Olanda 42
VN - Vietnam 40
DE - Germania 23
FI - Finlandia 18
HU - Ungheria 16
IE - Irlanda 16
CI - Costa d'Avorio 10
CA - Canada 5
GB - Regno Unito 4
HK - Hong Kong 4
RU - Federazione Russa 4
FR - Francia 2
IN - India 2
IR - Iran 2
SE - Svezia 2
BE - Belgio 1
BR - Brasile 1
CL - Cile 1
EU - Europa 1
GR - Grecia 1
IL - Israele 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MX - Messico 1
PE - Perù 1
PL - Polonia 1
RO - Romania 1
RS - Serbia 1
Totale 1.248
Città #
Chandler 124
Singapore 105
Ashburn 84
Naples 63
Santa Clara 58
Napoli 55
Amsterdam 40
Dong Ket 40
Millbury 26
Des Moines 17
Lawrence 17
Beijing 14
Boston 13
Nanjing 13
Princeton 11
Budapest 8
Helsinki 8
Washington 8
Fairfield 7
Munich 7
Dublin 6
Los Angeles 6
Milan 6
Mugnano Di Napoli 5
Szeged 5
Formia 4
Hong Kong 4
Ottawa 4
Rome 4
Shanghai 4
Wilmington 4
Woodbridge 4
Changsha 3
Ferrara 3
Frankfurt am Main 3
Guangzhou 3
Gödöllő 3
Limatola 3
Pomarico 3
Acerra 2
Avellino 2
Fuzhou 2
Harbin 2
Jacksonville 2
Lappeenranta 2
Moscow 2
Nanchang 2
Pune 2
San Severo 2
Shenyang 2
Afragola 1
Anshan 1
Belgrade 1
Brussels 1
Casale Monferrato 1
Casavatore 1
Casoria 1
Cesano Maderno 1
Chengdu 1
Chongqing 1
Clifton 1
Dallas 1
Falkenstein 1
Falls Church 1
Fiumicino 1
Frattamaggiore 1
Fremont 1
Islington 1
Jamaica Plain 1
Jiaxing 1
Kunming 1
Lamezia Terme 1
Laojunmiao 1
Lima 1
London 1
Lu'an 1
Marcianise 1
Mexico City 1
Palermo 1
Pioltello 1
Portici 1
Potenza 1
Pozzuoli 1
Prineville 1
Redwood City 1
Rho 1
San Francisco 1
Santa Maria La Carita 1
Santiago 1
Seattle 1
Simi Valley 1
Sindelfingen 1
Suzhou 1
Tangjin 1
Tianjin 1
Torre Del Greco 1
Torun 1
Vientiane 1
Ürümqi 1
Totale 866
Nome #
CHRONIC RHINOSINUSITIS IN CYSTIC FIBROSIS PATIENTS: SMELL EVALUATION 75
Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex alleles 59
Cystic Fibrosis: The Sense of Smell 59
Autonomic dysfunction in Alzheimer's disease: tools for assessment and review of the literature 57
Cystic Fibrosis: the sense of smell. 57
TAS2R38 is a novel modifier gene in patients with cystic fibrosis 56
Lung structure and function similarities between primary ciliary dyskinesia and mild cystic fibrosis: a pilot study 55
Olfactory performance in Cystic Fibrosis patients 50
Adiponectin Expression Is Modulated by Long-Term Physical Activity in Adult Patients Affected by Cystic Fibrosis 49
Inhalation therapy in cystic fibrosis 48
Reduced absorption and enhanced synthesis of cholesterol in patients with cystic fibrosis: a preliminary study of plasma sterols 47
Salivary cytokines and airways disease severity in patients with cystic fibrosis 46
The role of nasal washes in CF patients affected by chronic rhinosinusitis 46
Oxylipin profile in saliva from patients with cystic fibrosis reveals a balance between pro-resolving and pro-inflammatory molecules 46
The role of nasal washes in patients with Cystic Fibrosis affected by chronic rhinosinusitis 40
Extensive CFTR Gene Analysis Revealed a Higher Occurrence of Cystic Fibrosis Transmembrane Regulator-Related Disorders (CFTR-RD) among CF Carriers 39
Lumacaftor/ivacaftor improves liver cholesterol metabolism but does not influence hypocholesterolemia in patients with cystic fibrosis 38
Lipidomic alterations in human saliva from cystic fibrosis patients 36
Influence of pancreatic status on circulating plasma sterols in patients with cystic fibrosis 36
Impaired Ratio of Unsaturated to Saturated Non-Esterified Fatty Acids in Saliva from Patients with Cystic Fibrosis 36
Assessment of chest high-field magnetic resonance imaging in children and young adults with noncystic fibrosis chronic lung disease: comparison to high-resolution computed tomography and correlation with pulmonary function. 35
Supervised physical exercise improves clinical, anthropometric and biochemical parameters in adult cystic fibrosis patients: A 2-year evaluation 35
Cystic Fibrosis Patients with F508del/Minimal Function Genotype: Laboratory and Nutritional Evaluations after One Year of Elexacaftor/Tezacaftor/Ivacaftor Treatment 31
Physical activity regulates tnfα and il-6 expression to counteract inflammation in cystic fibrosis patients 31
The impact of cystic fibrosis on the working life of patients: A systematic review 31
Employment status and work ability in adults with cystic fibrosis 28
Incidental late diagnosis of cystic fibrosis following AH1N1 influenza virus pneumonia: A case report 21
Effectivenesss of ivacaftor in severe cystic fibrosis patients and non-G551D gating mutations 21
Nasal nitric oxide assessment in primary ciliary dyskinesia using aspiration, exhalation, and humming. 20
Risk of acute myocardial infarction after transurethral resection of prostate in elderly 15
Elexacaftor/Tezacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for the F508del Mutation and Advanced Lung Disease: A 48-Week Observational Study 14
Lung disease assessment in primary ciliary dyskinesia: a comparison between chest high-field magnetic resonance imaging and high-resolution computed tomography findings. 14
Cystic Fibrosis in Adults: A Paradigm of Frailty Syndrome? An Observational Study 12
One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical indexes 12
Liver biochemical indexes and cholesterol metabolism in cystic fibrosis patients with F508del/CFTR variant genotype after elexacaftor/tezacaftor/ivacaftor treatment 11
Beneficial economic effect of a virtual model of care for cystic fibrosis 10
Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease with the Phe508del/minimal function genotype 9
Clinical outcomes of a large cohort of individuals with the F508del/5T;TG12 CFTR genotype 9
Clinical outcomes of digital health in adults with cystic fibrosis 8
Totale 1.342
Categoria #
all - tutte 6.178
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.178


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202049 0 0 0 0 0 0 1 0 3 27 16 2
2020/2021105 11 0 22 10 1 3 2 10 2 4 0 40
2021/2022210 5 0 2 0 8 21 4 3 11 28 66 62
2022/2023328 31 23 17 15 37 38 8 19 68 47 18 7
2023/2024283 9 33 22 25 16 52 18 23 14 14 38 19
2024/2025270 58 44 0 31 39 98 0 0 0 0 0 0
Totale 1.342